gip glp-1 dual agonist GIPR/GLP-1R therapies for diabetes and weight loss– Chemistry, Physiology and Clinical application GLP-1 Receptor Agonists Explained for

Moreover, emerging evidence suggests that GLP-1RAs may confer cardiovascular protection, neuroprotective benefits, and positive effects on mental health

Receptors & Channels

Their major drawback is the subcutaneous route of administration, constituting a barrier to adoption and reason for treatment discontinuation

While GLP-1RAs were initially developed for glycemic control in T2DM, accumulating evidence supports their utility in managing obesity independent of diabetes

Accessed 20 Nov 2021 Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews